LMIM
CELG

Lockheed Martin Investment Management’s Celgene Corp CELG Stock Holding History

Lockheed Martin Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,080
Closed -$739K – 146
2017
Q4 		$739K Sell
7,080
-6,920
-49% -$781K 0.03% 106
2017
Q3 		$2.04M Buy
14,000
+4,000
+40% +$545K 0.11% 76
2017
Q2 		$1.3M Buy
+10,000
New +$1.23M 0.07% 101

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lockheed Martin Investment Management's CELG Position: Q1 2018 in Review

Lockheed Martin Investment Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 7,080 shares — an estimated $739K sold.

Lockheed Martin Investment Management first reported a position in CELG in Q2 2017 and held it in 3 quarters. The position peaked at $2.04M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Lockheed Martin Investment Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 7,080 Celgene Corp shares in Q1 2018, an estimated $739K.
  • Lockheed Martin Investment Management first reported a position in Celgene Corp in Q2 2017 and held it in 3 quarters.
  • Lockheed Martin Investment Management's Celgene Corp position peaked at $2.04M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2018, filed 26 Apr 2018.